In a study using a xenograft model with murine MBT-2 cells in immunocompetent mice [100], additive (not synergistic) effects of PD-L1 antibody + enzalutamide were seen, but it was not clear if enzalutamide independently inhibited the tumor growth. This evidence concerns the gene CD274 and neoplasm.